Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule. Here, we discuss the clinical presentations, histological and immunohistochemical features and treatment options for each type of primary breast lymphoma. We hope that this review will highlight the importance of the timely and accurate diagnosis of breast lymphoma in order to tailor the most appropriate treatment. We also wish to raise awareness of the breast implant-associated lymphomas, with the goal of stimulating work that will aid our understanding of their epidemiology and pathogenesis.

CEITEC Masaryk University Brno Czech Republic

Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas USA

Department of Pathology University of Cambridge Cambridge UK

See more in PubMed

World Health Organisation. Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer [Accessibility verified November 3, 2021].

Moura C, Leite MI, Parreira R, Medeiros A. Primary breast lymphoma. J Surg Case Reports. 2020;2020(1):1–3. PubMed PMC

Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705–1712. PubMed

Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: A study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32(9):1299–1309. PubMed

Shao YB, Sun XF, He YN, Liu CJ, Liu H. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature. Med Oncol. 2015;32(2):1–6. PubMed

Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary Breast Lymphoma in the United States: 1975–2013. JNCI J Natl Cancer Inst. 2017;109(6) PubMed PMC

Uenaka N, Yamamoto S, Sato S, et al. Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case report. Clin Case Reports. 2021;9(6) PubMed PMC

Marton I, Hrgović Z, Habek D. Primary hodgkin's lymphoma of the breast initially treated by surgical excision and axillary dissection. Acta Clin Croat. 2020;59(2):365. PubMed PMC

Chen M, Zhou J, Qu X. Primary Breast Diffuse Large B-Cell Lymphoma in a 42-Year-Old Female: A Case Report and Review of Literature. J Med Cases. 2021;12(5):181. PubMed PMC

Yoneyama K, Nakagawa M, Hara A. Primary lymphoma of the breast: A case report and review of the literature. Radiol Case Reports. 2021;16(1):55. PubMed PMC

Teras LR, Patel A.V., Hildebrand JS, Gapstur SM. Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort. Leuk. Lymphoma. 2012;54(4):720–725. PubMed

Shen F, Li G, Jiang H, Zhao S, Qi F. Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature. Medicine (Baltimore) 2020;99(33):e21736. PubMed PMC

Yin Y, Ye M, Chen L, Chen H. Giant primary breast diffuse large B-cell lymphoma during pregnancy and lactation. Breast J. 2019;25(5):996–997. PubMed

Villalón-López JS, Souto-del Bosque R, Méndez-Sashida PG. Linfoma no Hodgkin primario de la glándula mamaria. Reporte de un caso. Cir Cir. 2017;85(1):70–75. PubMed

Wadhwa A, Senebouttarath K. Primary lymphoma of the breast: A case series. Radiol Case Reports. 2018;13(4):815. PubMed PMC

Terada T. Follicular Lymphoma of Breast. Breast J. 2016;22(3):356–357. PubMed

Martinelli G, Ryan G, Seymour JF, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009;20(12):1993–1999. PubMed

Mirkheshti N, Mohebtash M. A rare case of bilateral breast lobular carcinoma coexisting with primary breast follicular lymphoma. J Community Hosp Intern Med Perspect. 2019;9(2):155. PubMed PMC

Michalinos A, Vassilakopoulos T, Levidou G, Korkolopoulou P, Kontos M. Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence? J Breast Cancer. 2015;18(3):296. PubMed PMC

Tiong TYV, Alsannaa SM, Soon STG, Poon LM, Goh YG. A rare case of primary follicular lymphoma of the breast in a male patient. Breast J. 2020;26(7):1404–1406. PubMed

Miura S, Hashimoto H, Sawada T, Ishida T, Usuki K, Morikawa T. CD10-Negative Primary Breast Follicular Lymphoma: A Rare Case of Primary Breast Lymphoma With an Atypical Immunophenotype Mimicking Marginal Zone Lymphoma. Int. J. Surg. 2020;29(4):400–403. PubMed

Ismail S, Kherbek H, Skef J, Naser Eldine M, Alshehabi Z. Primary marginal zone lymphoma of the breast; a rare case report and review of the literature. Hum Pathol Case Reports. 2020;22

Talluri S, Subramanian CR, Werner E, Kasireddy V, Philip L. Bilateral Primary Marginal Zone Lymphoma of the Breast – A Rare Breast Malignancy. In Vivo (Brooklyn) 2020;34(6):3597. PubMed PMC

Parashar K, Nepal P, Assaker R, Vargas J, Rosasco S. Incidentally detected Non-Hodgkin's lymphoma of the breast. A case report with review of literature. Radiol Case Reports. 2021;16(1):205–209. PubMed PMC

Liguori G, Cantile M, Cerrone M, et al. Breast MALT lymphomas: A clinicopathological and cytogenetic study of 9 cases. Oncol Rep. 2012;28(4):1211–1216. PubMed

Gluskin J, D'Alessio D, Kim AC, Morris EA, Chiu A, Noy A. Primary lymphoma of the breast: A report of two cases. Clin Imaging. 2020;68:295–299. PubMed PMC

Wei Lin C, Xu C, Xi Q, Wang C. Primary Burkitt's lymphoma of the breast without Epstein-Barr virus infection: A case report and literature review. Indian J Pathol Microbiol. 2015;58(4):546. PubMed

Testa AC, De Blasis I, Di Legge A, Belli P, Hohaus S, Ferrandina G. Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy. Ultrasound Obstet Gynecol. 2013;42(3):364–366. PubMed

Janbabai G, Kayedimajd S, Alian S, Naghshvar F, Rashidi M, Farazmandfar T. Bilateral breast swelling in a 23-year-old woman with Burkitt lymphoma. J Res Med Sci. 2012;17(12):1188. PubMed PMC

Negahban S, Ahmadi N, Oryan A, et al. Primary Bilateral Burkitt Lymphoma of the Lactating Breast. Mol Diagnosis Ther. 2012;14(4):243–250. PubMed

Elgaafary S, Nagel I, López C, et al. Double-hit lymphoma of the male breast: a case report. J Med Case Rep. 2020;14(1) PubMed PMC

Meucci R, Pistolese CA, Perretta T, et al. Primary Extranodal Follicular T-Cell Lymphoma and Ductal Breast Carcinoma Diagnosed by a Magnetic Resonance Imaging-Guided Vacuum-Assisted Biopsy: A Case Report. Am J Case Rep. 2021;22(1) PubMed PMC

Turner SD. An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma. Anaplastic Lymphoma Kinase (ALK)-Positive. Cancers (Basel) 2017;9(10)

Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood. 2004;104(10):3358–3360. PubMed

Malcolm TIM, Villarese P, Fairbairn CJ, et al. Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nat Commun. 2016;7(1):1–12. PubMed PMC

Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin's. Lymphoma. Science. 1994;263(5151):1281–1284. PubMed

Turner SD, Yeung D, Hadfield K, Cook SJ, Alexander DR. The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms. Cell Signal. 2007;19(4):740–747. PubMed

Iyengar P, Reid-Nicholson M, Moreira AL. Pregnancy-associated anaplastic large-cell lymphoma of the breast: A rare mimic of ductal carcinoma. Diagn Cytopathol. 2006;34(4):298–302. PubMed

Minard-Colin V, Brugières L, Reiter A, et al. Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead. J Clin Oncol. 2015;33(27):2963. PubMed PMC

Sathyanarayanan V, Lokesh KN, Lakshmaiah K, et al. Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant. Ann Saudi Med. 2014;34(6):551. PubMed PMC

Ivashkevich Y, Chernov Y, Chinenov D, et al. Unusual Case of Anaplastic Large Cell Lymphoma Presenting as a Breast Mass in a Patient with no History of Breast Implants. Case Rep Pathol. 2020;2020:1–4. PubMed PMC

Yi JH, Kim SJ, Kim WS. Brentuximab vedotin: clinical updates and practical guidance. Blood Res. 2017;52(4):243. PubMed PMC

Lazzeri D, Agostini T, Bocci G, et al. ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity. Clin Breast Cancer. 2011;11(5):283–296. PubMed

Aguilera NSI, Tavassoli FA, Chu WS, Abbondanzo SL. T-Cell Lymphoma Presenting in the Breast: A Histologic, Immunophenotypic and Molecular Genetic Study of Four Cases. Mod Pathol. 2000;13(6):599–605. PubMed

Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ. Anaplastic Large Cell Lymphoma Involving the Breast: A Clinicopathologic Study of 6 Cases and Review of the Literature. Arch Pathol Lab Med. 2009;133(9):1383–1390. PubMed

Pina-Oviedo S, Ortiz-Hidalgo C, Carballo-Zarate AA, Zarate-Osorno A. ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas. Cancers (Basel) 2021;13(18) PubMed PMC

Brown RA, Fernandez-Pol S, Kim J. Primary cutaneous anaplastic large cell lymphoma. J Cutan Pathol. 2017;44(6):570–577. PubMed

Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood. 2014;124(9):1473–1480. PubMed PMC

Lobello C, Tichy B, Bystry V, et al. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leuk. 2020;35(5):1500–1505. PubMed PMC

Dogan ZA, Miranda RN, Iyer S, Steiner RE, Singh P, Clemens MW. Anaplastic Large Cell Lymphoma of the Breast Arising in a Burn Cicatrix. Aesthetic Surg J. 2020;40(4):NP159. PubMed PMC

Sasaki K, Sugaya M, Fujita H, et al. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation. Br J Dermatol. 2004;150(6):1202–1207. PubMed

Pulitzer M, Ogunrinade O, Lin O, Steinherz P. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient. J Cutan Pathol. 2015;42(3):182–187. PubMed PMC

Booken N, Goerdt S, Klemke CD. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry. JDDG J der Dtsch Dermatologischen Gesellschaft. 2012;10(5):331–339. PubMed

Bergsten TM, Principe DR, Raicu A, Rubin J, Ong AL, Hagen C. Non-implant associated primary cutaneous anaplastic large cell lymphoma of the breast. J Surg Case Reports. 2019;2019(5):1–3. PubMed PMC

Mehta-Shah N, Clemens MW, Horwitz SM. How I treat breast implant–associated anaplastic large cell lymphoma. Blood. 2018;132(18):1889–1898. PubMed PMC

Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: High-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140(4):645–654. PubMed

Miranda RN, Aladily TN, Prince HM, et al. Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients. J Clin Oncol. 2014;32(2):114. PubMed PMC

Akhavan AA, Wirtz EC, Ollila DW, Bhatt N. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab. Plast Reconstr Surg. 2021:299–303. PubMed

Freedman J, Peredo A, Rosser J, Christian N, Kaoutzanis C. Biopsy Results Are Not Sufficient to Exclude Breast Implant–associated Anaplastic Large Cell Lymphoma: A Case Mistaken for Disseminated Silicosis. Plast Reconstr Surg Glob Open. 2020;8(9) PubMed PMC

Clemens MW, Medeiros LJ, Butler CE, et al. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2016;34(2):160. PubMed PMC

Ferrufino-Schmidt MC, Jeffrey Medeiros L, Liu H, et al. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2018;42(3):293. PubMed PMC

D'Alessandris N, Lucatelli P, Tripodi D, Amabile MI, Ascoli V. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion. Diagn Cytopathol. 2019;47(11):1213–1217. PubMed

Evans MG, Medeiros LJ, Marques-Piubelli ML, et al. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol. 2021;34(12):2148–2153. PubMed

Tripodi D, Amabile MI, Varanese M, D'Andrea V, Sorrenti S, Cannistrà C. Large cell anaplastic lymphoma associated with breast implant: a rare case report presentation and discussion of possible management. Gland Surg. 2021;10(6):2076–2080. PubMed PMC

Johnson L, O'Donoghue JM, McLean N, et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017;43(8):1393–1401. PubMed

Richardson K, Alrifai T, Grant-Szymanski K, et al. Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature. Mol Clin Oncol. 2017;6(4):539. PubMed PMC

Thienpaitoon P, Disphanurat W, Warnnissorn N. Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand. Arch Plast Surg. 2020;47(5):478. PubMed PMC

Allchin RL, Wickenden K, Pilgrim S, Wilson-Morkeh I, Miall FM. The Successful Use of Neo Adjuvant Brentuximab Vedotin in the Treatment of BIA-ALCL. HemaSphere. 2020;4(6):e501. PubMed PMC

Berlin E, Singh K, Mills C, Shapira I, Bakst RL, Chadha M. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature. Case Rep Hematol. 2018;2018:1–6. PubMed PMC

Thibodeau R, Fan KL, Wehner PB. Stage IV Breast Implant–associated Anaplastic Large-cell Lymphoma with Complete Pathologic Response to Neoadjuvant Chemotherapy. Plast Reconstr Surg Glob Open. 2019;7(9):1. PubMed PMC

Alderuccio JP, Desai A, Yepes MM, Chapman JR, Vega F, Lossos IS. Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma. Clin Case Reports. 2018;6(4):634. PubMed PMC

Keech JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100(2):554–555. PubMed

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. PubMed PMC

Miranda RN, Feldman AL, Soares FA. Breast implant-associated anaplastic large cell lymphoma. In: K.H. Allison et al. (eds). World Health Organization Breast Tumours 245-248 (IARC: Lyon, 2019).

CocoRuby Plastic Surgery. Updated Breast Implant Cancer (BIA-ALCL): Everything We Know In 2021. https://cocorubyplasticsurgery.com.au/blog/update-on-breast-implant-associated-alcl-bia-alcl-everything-we-know-in-2021/ [Accessibility verified November 12, 2021].

Ohishi Y, Mitsuda A, Ejima K, et al. Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient. Breast Cancer. 2020;27(3):499. PubMed PMC

Lai CS, Wu CY, Chen IC, Tsai YC. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) – The first case in Taiwan. Asian J Surg. 2021;44(6):869–870. PubMed

Ionescu P, Vibert F, Amé S, Mathelin C. New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Eur J Breast Heal. 2021;17(4):302. PubMed PMC

De Jong D, Vasmel WLE, De Boer JP, et al. Anaplastic Large-Cell Lymphoma in Women With Breast Implants. JAMA. 2008;300(17):2030–2035. PubMed

Cordeiro PG, Ghione P, Ni A, et al. Risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in a Cohort of 3546 Women Prospectively Followed Long Term After Reconstruction with Textured Breast Implants. J Plast Reconstr Aesthet Surg. 2020;73(5):841. PubMed PMC

Santanelli Di Pompeo F, Sorotos M, Clemens MW, et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of Epidemiology and Prevalence Assessment in Europe. Aesthetic Surg J. 2021;41(9):1014–1025. PubMed

Lechner MG, Megiel C, Church CH, et al. Survival Signals and Targets for Therapy in Breast Implant–Associated ALK− Anaplastic Large Cell Lymphoma. Clin Cancer Res. 2012;18(17):4549–4559. PubMed

Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135(2):319–329. PubMed

Mempin M, Hu H, Vickery K, et al. Gram-Negative Bacterial Lipopolysaccharide Promotes Tumor Cell Proliferation in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Cancers (Basel) 2021;13(21) PubMed PMC

Deva AK, Turner SD, Kadin ME, et al. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers (Basel) 2020;12(12):1–14. PubMed PMC

Turner SD. The Cellular Origins of Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Implications for Immunogenesis. Aesthetic Surg J. 2019;39(Supplement_1):S21–S27. PubMed PMC

Tevis SE, Hunt KK, Miranda RN, Lange C, Butler CE, Clemens MW. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. Aesthetic Surg J. 2019;39(10):1065–1070. PubMed

Wang HY, Thorson JA, Hinds BR, et al. Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants. J Cutan Pathol. 2021;48(5):659–662. PubMed

Alcalá R, Llombart B, Lavernia J, Traves V, Guillén C, Sanmartín O. Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma. J Cutan Pathol. 2016;43(7):602–608. PubMed

Evans MG, Miranda RN, Young PA, et al. B-cell lymphomas associated with breast implants: Report of three cases and review of the literature. Ann Diagn Pathol. 2020;46 PubMed

Bletsis PP, Janssen LE, Visser O, et al. Bilateral breast implant associated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A case report. Int J Surg Case Rep. 2020;71:341. PubMed PMC

Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, et al. Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol. 2021;34(12):2154–2167. PubMed

Elia R, Maruccia M, De Pascale A, Di Napoli A, Ingravallo G, Giudice G. The management of breast implant-associated anaplastic large cell lymphoma in the setting of pregnancy: seeking for clinical practice guidelines. Arch Plast Surg. 2021;48(4):373. PubMed PMC

Misad S.C, Walker B.K, Valbuena JR, et al. Anaplastic large cell lymphoma associated with breast implants, diagnosed by fine needle aspiration. Report of one case. Rev Med Chil. 2020;148(8):1207–1212. PubMed